Tuesday, April 2, 2019

Proposed WellCare Purchase Offers Myriad Benefits for Centene


In a $17.3 billion deal that would make the country’s largest Medicaid managed care organization even larger, give it a greater foothold in Medicare, and perhaps shield it from some policy uncertainty, Centene Corp. said March 27 that it agreed to purchase WellCare Health Plans, Inc.
To Wall Street analysts, the tie-up makes sense — even if not all of them were expecting it.
“When the headlines hit last night, we were somewhat surprised given [Centene’s] already hefty Medicaid coverage/footprint, its strong track record of retaining/winning RFPs [requests for proposals], and weaker currency given recent stock performance,” Citi’s Ralph Giacobbe wrote in a March 27 note to investors. However, Centene has “done well with recent larger deals,” and WellCare does offer further scale and an opportunity to gain more MA business, he added.
Overall, “the deal puts Centene into a new tier as a significant player among the diversified MCOs and solidifies its growth path for years,” Oppenheimer’s Michael Wiederhorn wrote in a research note.
As Centene is also the country’s largest carrier of Affordable Care Act marketplace plans, some wondered whether its proposed purchase was a reaction to the continued uncertainty over the ACA’s future — particularly in light of the Trump administration’s recently shifted position on a lawsuit that seeks to throw out the entire law.
Indeed, Medicaid managed care expert Alex Shekhdar tells AIS Health, the move to acquire WellCare “may be a bit of a hedge” against that issue. But Centene CEO Michael Neidorff brushed aside concerns about the ACA’s future during a call with investors, calling it “headline volatility” and noting that the current litigation against the ACA has “a long way to play out.”

No comments:

Post a Comment